CoChat

Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights

Open access
Abdel-Mageed, Heidi M. · 2025 · Inflammopharmacology

The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.

Abstract

Atopic dermatitis (AD) is a paradigmatic prevalent, long-lasting, and inflammatory skin condition with a diverse range of clinical manifestations. The etiology and clinical symptoms of AD are influenced by complex pathophysiological processes, which involve a strong genetic component, epidermal dysfunction, and immunological dysregulation, and a strong influence of other physiological and environmental factors. The FDA has approved targeted and well-tolerated immunomodulators including biologics like dupilumab and crisaborole, and small molecules such as baricitinib, as novel therapies for AD. They effectively treat AD but are too expensive for most patients. The review provides an update on the state of knowledge of AD pathogenesis, discusses the available diagnostic and scoring indices, and provides a scientific foundation for treatment methods for AD. This review also presents data on clinical efficacy of innovative treatments’ considering recent guidelines, emphasizing the newest medications and ongoing trials. Finally, the new implication of artificial intelligence (AI) in AD management is explored, where AI can speed up diagnosis and therapy. The PubMed, Google Scholar, and ScienceDirect databases were used for this review. Graphical Abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10787-025-01642-z

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 An outline of atopic dermatitis pathogenesis and mechanism of action of therapeutic agents. Reproduced with permission from Nguyen et al. (2019). CRTH2 chemoattractant receptor homologs molecule expressed on TH2 cells, AhR aryl hydrocarbon receptor, IgE immunoglobulin-E, IL interleukin, and H4R histamine-4 receptor JAK/STAT PDE4 phosphodiesterase 4, R receptor, KOR κ-opioid receptor, NK1R neurokinin-1 receptor, Janus kinase/signal transducer and activator of transcription, and TSLP thymic stromal lymphopoietin
Figure 1 An outline of atopic dermatitis pathogenesis and mechanism of action of therapeutic agents. Reproduced with permission from Nguyen et al. (2019). CRTH2 chemoattractant receptor homologs molecule expressed on TH2 cells, AhR aryl hydrocarbon receptor, IgE immunoglobulin-E, IL interleukin, and H4R histamine-4 receptor JAK/STAT PDE4 phosphodiesterase 4, R receptor, KOR κ-opioid receptor, NK1R neurokinin-1 receptor, Janus kinase/signal transducer and activator of transcription, and TSLP thymic stromal lymphopoietinCC BY · PubMed Central
Figure 2 A demonstration of environmental and trigger factors that cause inflammation and the onset and severity of AD clinical course
Figure 2 A demonstration of environmental and trigger factors that cause inflammation and the onset and severity of AD clinical courseCC BY · PubMed Central
Figure 3 A diagrammatic representation of AD therapy based on the severity of the condition
Figure 3 A diagrammatic representation of AD therapy based on the severity of the conditionCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 162 references

Cited by

See all 58

Metadata

Authors
Abdel-Mageed, H. M.
Affiliations
National Research Centre (EG)
Corresponding author
Abdel-Mageed, Heidi M.
Venue
Inflammopharmacology
Published
2025-02-07
Volume
33
Issue
3
Pages
1161-1187
ISSN
  • 0925-4692 (ISSN-L)
  • 1568-5608
OpenAlex
W4407260598
Cited by
45
References
160
Citations by year
2026: 28 · 2025: 17
FWCI
7.71
Type
journal article
Language
en
Open access
Licence
Locations
  • Inflammopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Research Centre Egypt
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
atopic dermatitis, pathogenesis, genetic susceptibility, immune dysregulation, dupilumab, crisaborole, baricitinib, biologics, small molecule therapy, treatment efficacy, artificial intelligence in dermatology, treatment costs
MeSH terms
Animals, Artificial Intelligence, Dermatitis, Atopic, Humans, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights. https://app.cochat.ai/papers/10.1007/s10787-025-01642-z
The paper
Abdel-Mageed, H. M. (2025). Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01642-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.